Global Epilepsy Market Analysis


  • Type: Common Disease Area
  • Published : March 2021
  • Region: Worldwide
  • Country: Other
  • Report ID : 340

  • Format: PPT, PDF

Global Epilepsy Market Research Report: By Condition (Epilepsy Drug Resistant/Intractable Epilepsy, Others), By Diagnosis & Treatment (Diagnosis & Treatment), By End-use (Hospitals, Clinics, Ambulatory Surgical Centres, Diagnostic Centres, Others) – Forecast till 2028


Report Overview

The global epilepsy market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 8.95% during the forecast period.

Epilepsy is a neurological disorder which usually causes seizers, sensation and other problems as it causes abnormalities in the brain. Seizures are the main symptoms of the epilepsy which usually causes disturbance in person’s mental, sensory and motor functions. Tumour, head injuries, stroke, alcohol withdrawal, birth injuries among others are some of the common reason for the epilepsy.

Each year 150,000 Americans are identified with central nervous system disorder and every 1 in 26 U.S. people are diagnosed with this disease. After migraine, stroke and Alzheimer, Epilepsy is the fourth most common neurological disease.

Market Drivers

Increasing epilepsy cases among aging population is driving the market growth. Rising neurological diseases among population will also propel the growth of the market, and increasing brain injuries cases due to road accidents will also drive the growth of this market. Growing funding for R&D of epilepsy is also contributing as a factor for the market growth.


  1. Global Epilepsy Market Overview…………………………………………………………………
    1. Market Size
  2. Market Growth Drivers……………………………………………………..……………….
    1. Rising Prevalence Of Epilepsy Amongst The Geriatric Population
    2. Increasing Cases Of Brain Injuries Due To Road Accidents
    3. Rising Neurological Disorders
  3. Epilepsy Market Segmentation…..………………………………………………………………..
    1. By Condition
      1. Epilepsy Drug Resistant/ Intractable Epilepsy
      2. Others
    2. By Diagnosis and Treatment
      1. Diagnosis and Treatment
    3. By End Use
      1. Hospitals
      2. II. Clinics
      3. Ambulatory Surgical Centres
      4. Diagnostic Centres
      5. Others
    4. By Geography
      1. America Market Analysis
      2. Europe Market Analysis
      3. Asia-Pacific Market Analysis
      4. Middle-East and Africa Market Analysis
  4. Epilepsy Major Market Share by Revenue…………………………………………….
    1. Key Findings
    2. Market Analysis, Insights and Forecast
  5. Competitive Landscape………………………………………………………….………..
    1. Major Players
    2. Products in Pipeline
  6. Key Company Profiles…………………………………………………………………….
    1. GSK Company overview, Product & Services, Strategies & Financials
    2. Eisai Company overview, Product & Services, Strategies & Financials
    3. LivaNova Company, Product & Services, Strategies & Financials
  7. Healthcare Policies and Regulatory Landscape…………………………..…………
    1. Policy changes and Reimbursement scenario
  8. Factors Driving Future Growth…………………………………………………………..
    1. Key Industry Developments
  9. Potential Growth Opportunities………………………………………………………….
    1. Future Opportunities
  10. Conclusion

Market Segmentation

By Condition

By condition, the market is bifurcated into epilepsy drug-resistant/intractable epilepsy and others. The drug-resistant epilepsy segment is expected to hit a value of USD 5.7 billion by the end of the forecast period. The advent of rational polytherapy for treating disease with minimal side-effects is expected to produce substantial revenue for the epilepsy market.

By Diagnosis and Treatment:

By diagnosis and treatment, the market for epilepsy is segmented into diagnosis and treatment. The treatment category is expected to drive the market at a XX percent CAGR during the projected period due to the availability of inexpensive medications to treat partial epileptic seizures. In addition, the approval of successful drugs by regulatory authorities will promote the development of the segment. On the other hand, the diagnostic segment is expected to mature at XX percent CAGR over the evaluation period. The use of numerous imaging tests and blood tests to diagnose early on the condition is expected to accelerate segment development tenfold.

By End-Use:

Based on the end-users, the epilepsy market is segmented into hospitals, clinics, diagnostic centres, ambulatory surgical centres, and others. The hospital segment is touted to dominate the market growth over the review period, followed by the clinics segment. Moreover, hospitals that encourage the procurement of medicine from hospital premises are likely to promote the market.

By Region:

The epilepsy industry in the region is segmented into the Americas, Europe, Asia Pacific (APAC) and the Middle East and Africa (MEA).

North America dominates the market with superior healthcare infrastructure. North America is a leading contributor to the market due to the availability of well-established healthcare facilities, beneficial government policies aimed at strengthening the healthcare sector, and the presence of substantial research and development programs.
Growing R&D investments drive the Europe market. Increased investment in research and production of successful medications to cure epilepsy coupled with a high prevalence of the disease is expected to fuel regional demand exponentially in Europe.

Development of Novel Drugs to raise APAC market. The APAC market will grow due to the high occurrence of condition reported in the country. Also, the countries of India, South Korea and China, which are emerging as viable destinations for researching and producing novel products, will stimulate consumer demand over the forecast period.

Top Major Players

Companies active in the epilepsy therapeutics industry plan to strengthen their global reach through authorization by government agencies, partnerships, strategic mergers & acquisitions with other market leaders in their respective territories and regions around the world. In order to strengthen their position in the global market for epilepsy therapeutics, robust progressive research and development efforts and product pipelines and growing product approvals are crucial strategies followed by these players. To increase their market share, most of the major players are engaged in reinforcing their product portfolio. It is predicted that the launch of new medicines would facilitate the market expansion of anti-epileptic medication. The major players are LivaNova PLC, GlaxoSmithKlinePLC, Eisai Co. Ltd., Pfizer, Medtronic PLC, and others.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements